Biovitrum AB and Discovery Partners International, Inc. form research alliance
Under the terms of this agreement, Biovitrum will get access to DPI´s comprehensive compound collection and its proprietary process and data management tools. Financial terms of the collaboration are not disclosed.
"We are impressed by DPI's integrated drug discovery approach and expect that this will add significant value to our ongoing lead discovery programs," said Mats Pettersson, Chief Executive Officer of Biovitrum.
"We are delighted to begin this collaboration with Biovitrum, and we are pleased to be working together on this promising new program," said Taylor Crouch, President & COO of Discovery Partners.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.